Source link : https://www.newshealth.biz/health-news/guillain-barre-syndrome-rates-after-rsv-shots-in-sync-with-trial-data-cdc-says/
Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up were higher than expected, but the vaccine’s benefits still outweigh any small potential risk, according to a new CDC analysis. Data from the Vaccine Adverse Event Reporting System (VAERS) revealed that there were 1.5 reports of GBS per […]
Author : News Health
Publish date : 2024-05-31 21:44:05
Copyright for syndicated content belongs to the linked Source.
Categories